Interleukin-36 receptor antagonist is associated with the progression of renal cell carcinoma
International Immunopharmacology (2020) - Comments
doi: 10.1016/j.intimp.2020.106474  issn: 1567-5769  pubmed: 32298963  issn: 1878-1705 

Kuangkuang Zhu, Dong Sun, Xiaoqin Zou, Ruixia Liu, Zhen Wang